经股动脉颈动脉支架术预后按术前症状状态分层分析
本研究基于VQI数据库2016-2020年9807例经股动脉颈动脉支架术患者,按术前症状状态分层。近期卒中患者围术期卒中/死亡率为5.5%,显著高于近期半球性TIA(2.4%)、近期眼性TIA(2.8%)和无症状患者(1.4%)。多变量分析显示近期卒中与无症状状态相比OR为4.1,支持术前按神经损伤程度进一步分层评估风险。
要点
- 近期卒中患者TFCAS围术期卒中/死亡风险最高,达5.5%。
- 无症状患者风险最低(1.4%),但既往症状患者风险仍高于无症状(3.5%)。
- 术前风险评价应结合症状类型及神经损伤严重程度进行分层。
核心结论
- 近期卒中患者TFCAS后院内卒中/死亡风险高于近期半球性TIA。
- 既往症状状态患者卒中/死亡风险高于无症状患者。
研究设计与样本
- 回顾性队列研究,纳入Vascular Quality Initiative数据库2016-2020年接受TFCAS的患者共9807例。
- 按术前症状状态分为无症状、既往症状(>180天)和近期症状(<180天),近期症状细分为卒中、半球性TIA和眼性TIA。
主要发现
- 近期卒中患者围术期卒中/死亡率为5.5%,高于近期半球性TIA(2.4%;P < .001)、近期眼性TIA(2.8%;P = .03)和无症状患者(1.4%;P < .001)。
- 近期眼性TIA患者卒中/死亡率高于无症状患者(2.8% vs 1.4%;P = .04)。
- 既往症状患者卒中/死亡率高于无症状患者(3.5% vs 1.4%;P < .001)。
- 多变量调整后,近期卒中相比近期半球性TIA的OR为2.6(95%CI 1.6-4.3;P < .001),相比无症状的OR为4.1(95%CI 3.0-5.6;P < .001)。
- 无症状状态相比既往症状状态的OR为0.4(95%CI 0.2-0.6;P < .001)。
临床怎么用
- 术前风险评价应进一步按神经损伤程度分层,近期卒中患者风险最高。
- 无症状患者TFCAS风险较低,但仍需个体化评估。
局限性
- 数据来源于VQI数据库,可能存在回顾性偏倚。
- 未报告其他未测量混杂因素的调整情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The available data on outcomes after transfemoral carotid artery stenting (TFCAS) originate from the early experience with TFCAS. Although most previous studies stratified outcomes according to a symptomatic or asymptomatic presentation, they often did not specify the degree of presenting neurologic injury. We previously reported that the outcomes after carotid endarterectomy differed according to neurologic injury severity, the contemporary perioperative outcomes of TFCAS stratified by the specific presenting symptom status are unknown. METHODS: Patients with data in the Vascular Quality Initiative database who had undergone TFCAS from 2016 to 2020 were included. We stratified patients according to their preprocedural symptom status as asymptomatic, formerly symptomatic (last symptoms >180 days before the procedure), or recently symptomatic (symptoms <180 days before the procedure). The symptoms included stroke, hemispheric transient ischemic attack (TIA), and ocular TIA. We compared the occurrence of in-hospital stroke or death (stroke/death) among the asymptomatic, formerly symptomatic, and specific subtypes of recently symptomatic patients. Multivariable logistic regression models were constructed to adjust for the baseline differences among the groups. RESULTS: Of the 9807 included patients, 2650 (27%) had had recent stroke, 842 (9%), recent hemispheric TIA, and 360 (4%), recent ocular TIA. In addition, 795 patients (8%) were formerly symptomatic and 5160 (53%) were asymptomatic. The patients with recent stroke had a perioperative stroke/death rate of 5.5%, higher than that of patients with recent hemispheric TIA (2.4%; P < .001) or recent ocular TIA (2.8%; P = .03) and asymptomatic patients (1.4%; P < .001). The stroke/death rate was greater for patients with recent ocular TIA than for asymptomatic patients (2.8% vs 1.4%; P = .04). Formerly symptomatic patients had higher stroke/death rates compared with asymptomatic patients (3.5% vs 1.4%; P < .001). On multivariable-adjusted analysis, recent stroke was associated with higher stroke/death compared with recent hemispheric TIA (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.6-4.3; P < .001) and asymptomatic status (OR, 4.1; 95% CI, 3.0-5.6; P < .001) and demonstrated a trend toward higher stroke/death compared with recent ocular TIA (OR, 2.0; 95% CI, 1.0-3.9; P = .06). Furthermore, asymptomatic status was associated with lower stroke/death compared with formerly symptomatic status (OR, 0.4; 95% CI, 0.2-0.6; P < .001). CONCLUSIONS: For patients undergoing TFCAS, recent stroke was associated with greater odds of in-hospital stroke/death after TFCAS compared with recent hemispheric TIA. Also, formerly symptomatic status was associated with greater odds of stroke/death compared with asymptomatic status. These findings support further symptom stratification by the degree of the presenting neurologic injury in the preoperative risk assessment.
引用
- Solomon Y, Varkevisser RRB, Swerdlow NJ, et al. Outcomes after transfemoral carotid artery stenting stratified by preprocedural symptom status. J Vasc Surg. 2020. PMID: 33278538. doi:10.1016/j.jvs.2020.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。